Aspirin: benefits and risks in cardiovascular disease - a podcast by BMJ Group
from 2016-12-20T18:59:30
::
::
In this second Evidence-Based Medicine podcast, Associate Editor Terrence Shaneyfelt interviews Salim Virani, from the Health Services Research and Development, Houston, USA. Professor Virani is the leading author of the systematic review with meta analysis, "Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding".
Read the article here: http://ebm.bmj.com/content/early/2016/10/25/ebmed-2016-110531.extract.
Further episodes of EBM
Further podcasts by BMJ Group
Website of BMJ Group